EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dual impacts of a glycan shield on the envelope glycoprotein B of HSV-1: evasion from human antibodies in vivo and neurovirulence

Ayano Fukui iD, Yuhei Maruzuru iD, Shiho Ohno, Moeka Nobe, Shuji Iwata, Kosuke Takeshima, Naoto Koyanagi, Akihisa Kato, Shinobu Kitazume, Yoshiki Yamaguchi, Yasushi Kawaguchi iD

mBio · 2023

DOI: 10.1128/mbio.00992-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mBio, 2023. Verfasst von Ayano Fukui und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Molecular Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo , Tokyo, Japan. Hauptthemen laut MEDLINE: Herpesvirus 1, Human, Herpes Simplex. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MEXT | Japan Society for the Promotion of Science, MEXT | Japan Science and Technology Agency, Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Identification of the mechanisms of viral evasion from human antibodies is crucial both for understanding viral pathogenesis and for designing effective vaccines. Here we show in cell cultures that an N-glycan shield on the herpes simplex virus 1 (HSV-1) envelope glycoprotein B (gB) mediated evasion from neutralization and antibody-dependent cellular cytotoxicity due to pooled γ-globulins derived from human blood. We also demonstrated that the presence of human γ-globulins in mice and immunity to HSV-1 induced by viral infection in mice significantly reduced replication in their eyes of a mutant virus lacking the glycosylation site but had little effect on the replication of its repaired virus. These results suggest that an N-glycan shield on a specific site of HSV-1 envelope gB mediated evasion from human antibodies in vivo and from HSV-1 immunity induced by viral infection in vivo . Notably, we also found that an N-glycan shield on a specific site of HSV-1 gB was significant for HSV-1 neurovirulence and replication in the central nervous system of naïve mice. Thus, we have identified a critical N-glycan shield on HSV-1 gB that has dual impacts, namely evasion from human antibodies in vivo and viral neurovirulence. IMPORTANCE Herpes simplex virus 1 (HSV-1) establishes lifelong latent and recurrent infections in humans. To produce recurrent infections that contribute to transmission of the virus to new human host(s), the virus must be able to evade the antibodies persisting in latently infected individuals. Here, we show that an N-glycan shield on the specific site of the envelope glycoprotein B (gB) of HSV-1 mediates evasion from pooled γ-globulins derived from human blood both in cell cultures and mice. Notably, the N-glycan shield on the specific site of gB was also significant for HSV-1 neurovirulence in naïve mice. Considering the clinical features of HSV-1 infection, these results suggest that the glycan shield not only facilitates recurrent HSV-1 infections in latently infected humans by evading antibodies but is also important for HSV-1 pathogenesis during the initial infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Herpesvirus 1, HumanHerpes SimplexHumansAnimalsMiceReinfectionViral Envelope ProteinsAntibodies, Neutralizinggamma-Globulins

Stichwörter der Autor:innen

glycan shieldherpes simplex virusimmune evasion

Substanzen

Viral Envelope ProteinsAntibodies, Neutralizinggamma-Globulins

Autor:innen und Institutionen

  • Division of Molecular Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo , Tokyo, Japan.
  • Department of Infectious Disease Control, International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo , Tokyo, Japan.
  • Research Center for Asian Infectious Diseases, The Institute of Medical Science, The University of Tokyo , Tokyo, Japan.
  • Division of Structural Glycobiology, Institute of Molecular Biomembrane and Glycobiology, Tohoku Medical and Pharmaceutical University , Miyagi, Japan.
  • Department of Clinical Laboratory Sciences, School of Health Sciences, Fukushima Medical University , Fukushima, Japan.
  • The University of Tokyo, Pandemic Preparedness, Infection and Advanced Research Center , Tokyo, Japan.

ORCID-Profile: Ayano Fukui, Yuhei Maruzuru, Yasushi Kawaguchi

Förderung

  • MEXT | Japan Society for the Promotion of Science
  • MEXT | Japan Science and Technology Agency
  • Japan Agency for Medical Research and Development

Zitieren

APA

Fukui, A., Maruzuru, Y., Ohno, S., Nobe, M., Iwata, S., Takeshima, K., Koyanagi, N., Kato, A., Kitazume, S., Yamaguchi, Y., & Kawaguchi, Y. (2023). Dual impacts of a glycan shield on the envelope glycoprotein B of HSV-1: evasion from human antibodies in vivo and neurovirulence. mBio. https://doi.org/10.1128/mbio.00992-23

Vancouver

Fukui A, Maruzuru Y, Ohno S, Nobe M, Iwata S, Takeshima K, et al. Dual impacts of a glycan shield on the envelope glycoprotein B of HSV-1: evasion from human antibodies in vivo and neurovirulence. mBio. 2023. doi:10.1128/mbio.00992-23

BibTeX
@article{Fukui2023,
  author = {Fukui, Ayano and Maruzuru, Yuhei and Ohno, Shiho and Nobe, Moeka and Iwata, Shuji and Takeshima, Kosuke and Koyanagi, Naoto and Kato, Akihisa and Kitazume, Shinobu and Yamaguchi, Yoshiki and Kawaguchi, Yasushi},
  title = {Dual impacts of a glycan shield on the envelope glycoprotein B of HSV-1: evasion from human antibodies in vivo and neurovirulence},
  journal = {mBio},
  year = {2023},
  doi = {10.1128/mbio.00992-23}
}
Kostenlos starten →